J Breast Cancer.
2024 Jun;27(3):147-162. 10.4048/jbc.2024.0085.
Breast Cancer and Therapy-Related Cardiovascular Toxicity
- Affiliations
-
- 1Department of Cardiology, Kyung Hee University College of Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea
- 2Department of Surgery, Kyung Hee University College of Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea
- KMID: 2557644
- DOI: http://doi.org/10.4048/jbc.2024.0085
Abstract
- The global incidence of breast cancer is on the rise, a trend also observed in South Korea. However, thanks to the rapid advancements in anticancer therapies, survival rates are improving. Consequently, post-treatment health and quality of life for breast cancer survivors are emerging as significant concerns, particularly regarding treatment-related cardiotoxicity. In this review, we delve into the cardiovascular complications associated with breast cancer treatment, explore surveillance protocols for early detection and diagnosis of late complications, and discuss protective strategies against cardiotoxicity in breast cancer patients undergoing anticancer therapy, drawing from multiple guidelines.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Exercise Prescription for Cardiovascular Health in Breast Cancer Survivors
- Role of ¹â¸F-FDG PET-CT in Monitoring the Cyclophosphamide Induced Pulmonary Toxicity in Patients with Breast Cancer: 2 Case Reports
- Mono- and Combination Chemotherapy for Metastatic Breast Cancer: An Increamental Step Forward
- Preliminary Result of Concurrent Chemotherapy and Rediotherapy in Stage I and II Breast Cancer Patients Treated with Breast Conservation Surgery
- Neoadjuvant Therapy Should Be the Standard of Care for Every Node Positive Breast Cancer Patient
